• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment


5.3400 USD 0.0500 0.95%

As of 11:10:51 ET on 01/26/2015.

Snapshot for Cerus Corp (CERS)

Open: 5.2600 Day's Range: 5.1900 - 5.3800 Volume: 246,673
Previous Close: 5.2900 52wk Range: 3.4800 - 8.0000 1-Yr Rtn: -14.50%

Stock Chart for CERS

No chart data available.
  • CERS:US 5.3300
  • 1D
  • 1M
  • 1Y
Interactive CERS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CERS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3811
Est. EPS (USD) (12/2014) -0.5320
Est. PEG Ratio -
Market Cap (M USD) 475.75
Shares Outstanding (M) 89.93
30 Day Average Volume 2,100,591
Price/Book (mrq) 8.8491
Price/Sale (ttm) 10.7947
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/25/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CERS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CERS

Cerus Corporation develops systems designed to enhance the safety of blood transfusions. The Company's systems inactivate pathogens in blood components and inactivate white blood cells, which are responsible for a variety of adverse transfusion reactions. Cerus' platform technologies prevent viral, bacterial, and cellular replication.

William Mariner Greenman "Obi"President/CEOChrystal N MenardChief Legal Officer
Caspar HogeboomPres:Cerus EuropeLaurence M CorashSenior VP/Chief Medical Ofcr/Co-Founder
More Company Profile & Key Executives for CERS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil